ERN-EuroBloodNet, the ERN on Rare Hematological Diseases (RHDs)

Contact us   |  

Highlights

Outcomes of the ERN-EuroBloodNet meeting at the EHA Congress 2024

During the EHA Congress, the ERN-EuroBloodNet meeting took place on 13 June 2024, focusing on "ERN-EuroBloodNet and ENROL Registry: Boosting data driven research and innovative therapies & fostering best practices and access to highly specialized care"

Interesting outcomes have been obtained from the discussions among the 88 attendants, from 45 ERN-EuroBloodNet Healthcare providers and 14 EU Member StatesDiscover all of them here!

The rare disease community comes together in calling on the EU institutions and our national governments to stand by the European Reference Networks

On 3 October 2023, the 24 ERN Coordinators, ePAGs representing their ERN on the EURORDIS, ePAGs Steering Committee (Loris Brunetta & Jacqueline Dubow for the ERN-EuroBloodNet), and EURORDIS co-signed an Open Letter calling on EU institutions and national governments to stand by European Reference Networks.

Discover the Open Letter together with the Press Release from EURORDIS!

“Sickle cell disease landscape and challenges in the EU: the ERN-EuroBloodNet perspective” has been published at The Lancet Haematology!

The Viewpoint summarizes the role of ERN-EuroBloodNet to improve the overall approach and management of Sickle cell disease patients in EU through key actions developed by the network. The manuscript is the result of the joint work within 12 EU Member States, a total of 26 ERN-EuroBloodNet health professionals and patients representatives have contributed.

Clinical Patient Management System (CPMS)

The Clinical Patient Management System (CPMS) is currently used by 122 ERN-EuroBloodNet users across 18 EU countries. 52 Panels have been opened so far in the platform from which 22 are closed, and 30 are still open for additional contributions. If you want to be part of this project, we recommend you to have a look at our website section where dedicated guides have been recently updated!

All 24 ERNs united to help Ukrainian people with rare diseases

All 24 European Reference Networks (ERNs) has launched a dedicated website and social media campaign to collect information to help health professionals to find support for Ukrainian patients with rare diseases: diagnosis, treatment, advice. Please don't hesitate to contacting us for rare haematological patients in need of highly specialized diagnosis or treatment for their rare disease: coordination@eurobloodnet.eu

Press&News

Keep informed about the latest information on Rare Hematological Diseases!

New survey! Expectations/requirements for a potential gene editing for Pyruvate Kinase Deficiency (PKD) and Congenital Dyserythropoietic Anemia (CDA)

This survey is designed to gather insights into patients' expectations and requirements for potential gene therapy treatments for Pyruvate Kinase Deficiency (PKD) and Congenital Dyserythropoietic Anemia (CDA).

New webinar program! Topic on Focus: EU Health Policy for patients organizations

The webinar program is co-led by ERN-EuroBloodNet & FITHAD and will be held in Italian

Europe-wide survey on transition and transfer procedures in rare diseases within the European Reference Networks (ERNs)

Are you involved in the care of patients with rare diseases? Your insights are crucial to improving continuity of care and shaping future strategies for rare disease patients across Europe.

The Clinical Patient Management System 2.0 (CPMS) mobile apps are now available!

CPMS 2.0 mobile applications are now live and available to the general public on the Apple App Store and Google Play Store.

Charter for Optimal Transitions from Paediatric to Adult Care in Sickle Cell Disease.

The Charter for Optimal Transitions from Paediatric to Adult Care in Sickle Cell Disease was launched alongside the EHA conference in Milan on 12 June!

Latest tweets

Euro Blood Net